Aroda, M.D., from Brigham and Women's Hospital in Boston, and colleagues randomly assigned adults with type 2 diabetes inadequately controlled with diet and exercise to receive once-weekly subcutaneous cagrilintide 2.4 mg plus semaglutide 2.4 mg, cagrilintide 1.0 mg plus semaglutide 1.0 mg, or placebo for 40 weeks (62, 63, and 64 participants, respectively)
Increased muscle growth and bone density
Qing-Xin-Jie-Yu Granule inhibits ferroptosis and stabilizes atherosclerotic plaques by regulating the GPX4/xCT signaling pathway
Research also indicates reduced fibrosis and improved functional recovery following injury
Geriatric For elderly patients, appropriate dose reduction and strict monitoring is required during therapy 4.7 Effects on ability to drive and use machines No studies on the effects on the ability to drive and use machines have been performed
Look out for fatigue , weakness , and neurological changes like numbness